Every Alternative to Rx.com

Baseline for every row below

What sends readers looking past Rx.com

Most readers arrive here with a specific complaint rather than a general one. Four come up again and again: the standing monthly price, whether Rx.com treats patients in their state, whether the vial is compounded or a brand-name pen, and how much clinician contact the plan actually includes. We cannot tell you which of those matters most to you. What we can do is put every other seller in the same category alongside Rx.com on all four, so the trade-off is visible instead of implied.

Four things worth checking before you switch

Nearly every real difference between GLP-1 telehealth sellers sits in one of four places. Read the list above against these and the shortlist usually gets short on its own.

• The month-two price, not the headline. A low first month that steps up afterward is the most common way a GLP-1 price gets quoted. Our "From" column carries the standing rate instead, so the comparison runs on the number you keep paying rather than the one on the ad.
• Compounded vial or brand-name pen. Compounded semaglutide and tirzepatide are the cheaper route, which is where most cash-pay readers end up. The trade is that a compounded vial has not been through FDA review the way Wegovy and Zepbound have. If that weighs on you, filter to sellers shipping the approved pen.
• Whether it ships to your state. State coverage is the thing most likely to end a signup halfway through. Each seller's review page lists the states it treats, so check yours before you start an intake.
• What happens after the first vial. Titration is where people get stuck, and it is also where these plans differ most. Clinician messaging, coaching and dietitian access are bundled by some sellers and billed separately by others. Neither approach is wrong. Work out which one you will actually use before you pay for it.